close

Enter

Log in using OpenID

Injectable Drug Delivery Market

embed
Injectable Drug Delivery Market - Size, Share,
Growth, Outlook, and Opportunity Analysis,
2018-2026
Injectables offer maximum bioavailability of drugs towards the intended site of action and avoid the
first pass metabolism. The injectable route is mostly preferred for the drugs which can’t be taken
orally or have some stability problems. Unconscious patients or patients having low compliance
towards oral tablets or capsules can be preferred for the injectable drug delivery therapy.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/2768
Injectable drug delivery is considered as the most effective route of administration for the effective
delivery of drugs to the targeted site, which enhances the patient’s compliance to the drug. The
Injectable delivery enhances the rapid absorption of drug from various sites such as subcutaneous,
intravenous, and intramuscular. The injectable delivery increases the bioavailability of the drug at the
systemic circulation, which offers availability of drug at intended site of action.
Increasing prevalence of chronic diseases such as diabetes and anaphylaxis is
expected to propel growth of the global injectable drug delivery market
Increasing prevalence of chronic diseases such as diabetes and other diseases is expected to
drive the market growth. According to the World Health Organization (WHO), in November 2011,
around 60 million people in Europe suffered from diabetes, of which around 10.3% were men and
9.6% were women aged 25 years and above. Similarly, according to World Health Organization
(WHO) 2018 factsheet, around 8.5% adults aged 18 years and above had diabetes in 2014
globally.
Moreover, the market players are focused on product development and launch of injectors, which
is expected to propel growth of the global injectable drug delivery market over the forecast
period. For instance, in 2016, Berlin-Chemie launched BerliPen areo 3 in Germany. BerliPen areo
3 is a 300 unit insulin pen, which can be used with six different insulins in the treatment of type 1
and 2 diabetes. Similarly, in August 2018, Teva Pharmaceuticals received the U.S. Food and Drug
Administration (FDA) approval for generic version of Mylan’s EpiPen and EpiPen Jr. Teva
Pharmaceuticals is the first generic manufacturer that received the FDA approval.
Report includes chapters which deeply display the following deliverable about industry :
• Injectable Drug Delivery Market Research Objective and Assumption
• Injectable Drug Delivery Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Injectable Drug Delivery Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value
Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Injectable Drug Delivery Market, By Regions
• Injectable Drug Delivery Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Injectable Drug Delivery Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Injectable Drug Delivery Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Injectable Drug Delivery Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key Players
Major players operating in the global injectable drug delivery market include Becton,
Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-ZeissStiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group,
Owen Mumford Limited, and Injex Pharma GmbH
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2768
Detailed Segmentation:
• Global Injectable Drug Delivery Market,
• Prefilled Syringes
• Auto Injectors
• Pens
• Conventional Syringes
• Cartridges
• Ampoules
• Vials
• Others
• Global Injectable Drug Delivery Market,
• Glass
• Plastic
• Global Injectable Drug Delivery Market,
• Disposable
• Reusable
• Global Injectable Drug Delivery Market,
• Intravenous
• Intramuscular
• Subcutaneous
• Global Injectable Drug Delivery Market,
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Others
• Global Injectable Drug Delivery Market,
• North America
By Device Type:
By Material Type:
By Usability:
By Route of Administration:
By End User:
By Region:
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Rushikesh
Rushikesh52   documents Email
Document
Category
Health and Medicine
Views
2
File Size
169 KB
Tags
injectable
1/--pages
Report inappropriate content